| Literature DB >> 34725461 |
Feng Wang1,2, Jiayi Zhang1,2, Houyi Tang1,2, Yi Pang3, Xiaoxue Ke1,2, Wen Peng1,2, Shitong Chen1,2, Muhammad Nadeem Abbas1,2, Zhen Dong1,2, Zhaobo Cui4, Hongjuan Cui5,6.
Abstract
Gastric cancer (GC) has the fifth highest incidence globally, but its molecular mechanisms are not well understood. Here, we report that coactivator-associated arginine methyltransferase 1 (CARM1) is specifically highly expressed in gastric cancer and that its overexpression correlates with poor prognosis in patients with gastric cancer. Nucleoporin 54 (Nup54) was identified as a CARM1-interacting protein that promoted CARM1 nuclear importation. In the nucleus, CARM1 cooperates with transcriptional factor EB (TFEB) to activate Notch2 transcription by inducing H3R17me2 of the Notch2 promoter but not H3R26me2. Additionally, the Notch2 intracellular domain (N2ICD) was identified as a CARM1 substrate. Methylation of N2ICD at R1786, R1838, and R2047 by CARM1 enhanced the binding between N2ICD and mastermind-like protein 1 (MAML1) and increased gastric cancer cell proliferation in vitro and tumor formation in vivo. Our findings reveal a molecular mechanism linking CARM1-mediated transcriptional activation of the Notch2 signaling pathway to Notch2 methylation in gastric cancer progression.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34725461 DOI: 10.1038/s41388-021-02078-9
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867